Janssen Biotech, Inc. Company Profile
✉ Email this page to a colleague
Summary for Janssen Biotech, Inc.
Patents: | 0 |
Tradenames: | 12 |
Ingredients: | 11 |
BLAs: | 13 |
Biologic Drugs for Janssen Biotech, Inc.
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 1994-12-22 | ⤷ Sign Up | |
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 1998-08-24 | ⤷ Sign Up | |
Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 2009-09-25 | ⤷ Sign Up | |
Janssen Biotech, Inc. | SIMPONI | golimumab | Injection | 125289 | 2009-04-24 | ⤷ Sign Up | |
Janssen Biotech, Inc. | SIMPONI ARIA | golimumab | Injection | 125433 | 2013-07-18 | ⤷ Sign Up | |
Janssen Biotech, Inc. | CARVYKTI | ciltacabtagene autoleucel | For Injection | 125746 | 2022-02-28 | ⤷ Sign Up | |
Janssen Biotech, Inc. | DARZALEX | daratumumab | Injection | 761036 | 2015-11-16 | ⤷ Sign Up | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |